New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Friday the 13th spells bad news for omega-3s

Friday the 13th spells bad news for omega-3s
Negative media is mounting on omega-3s. Here's the background you should know to keep customers informed.

The omega-3 category, in a downturn for the last two years starting with an erroneous study on prostate cancer and continuing with a combination of a lack of good news and a trickle of bad, is about to experience another hit in the mainstream press.

On Friday, Nov. 13, two Canadian television shows, Marketplace and The Fifth Estate, will air programs talking about the big, bad dietary supplements - focusing on a couple different supplement categories, including more negative news about omega-3s, and also on oxidation issues that question fish-oil safety.

In January, the American PBS show Frontline will air their story that covers the same ground around safety and efficacy.

Adam Ismail, executive director of the Global Organization for EPA and DHA Omega-3s, an industry trade group, was interviewed for the television programs and said the questions were leading and one-sided. He is not optimistic about the presentation.

“It doesn’t surprise me we’re challenged on the science,” Ismail told New Hope. “There are so many papers on omega-3; even though there are more randomized, controlled clinical trials and scientific papers on omega-3s than most pharmaceuticals, it doesn’t mean everything is going to continue to show positive results because you don’t want to do the same science over and over again, and you won’t find positive results on all the different things being studied.”

He said the larger problem is an expectation that nutrition is treated like pharmaceutical medicine, and nutrition is not going to give as powerful an impact as drugs. Another issue is consumer media.

“Headlines are not nuanced at all and yet they’re talking about nuanced science,” Ismail said. “An example just last week was a study and headlines which said omega-3s don’t help depression at all. But if you look at the paper, it does help depression though it’s just a small benefit, but a bigger benefit among patients getting treatment for clinical depression. But the headlines boiled it down to ‘Omega-3s don’t help depression.’”

On the issue of oxidation, there are two issues at play that confound the media celebration that omega-3 supplements are oxidized and dangerous. One is that flavorings used in omega-3 supplements, especially liquids, interfere with the method used to measure oxidation. This was a problem faced by omega-3 supplement leader Nordic Naturals a couple years ago.

The second part of the oxidation equation is “inaccurate executing methods” done in academia, said Ismail. That means the procedures used in academic labs confound results, usually by letting oxygen hit the oils before measuring oxidation levels.

What are retailers to tell customers?

Omega-3s have a long history of published research showing pronounced health benefits on various markers of cardiovascular health. The big three are reduction in triglyceride levels by 20-40 percent (the pharma drug Lovaza is nothing more than high-dose fish oil prescribed for elevated triglyceride levels); reduction in blood pressure; and a significant overall reduction in cardiovascular disease deaths. The reduction in deaths, according to every human clinical trial published during the last 10 years, is anywhere from 9 to 35 percent.

The recent studies throwing into question the heart-health benefits of omega-3s are being misinterpreted by “poor quality of reporting on these issues,” according to Ismail.

“These recent studies have had severe limitations,” he said. “They were not designed to answer the question of whether omega-3s work for heart health. They’re more about does a low dose of EPA and DHA help congestive heart patients who have been highly medicated with pharmaceuticals, within six months? That doesn’t tell you if omega-3s are good for your heart. There are extreme levels of constancy among researchers that find reduction in coronary death risk, reduced triglycerides, reduced blood pressure. If you ask a cardiologist, they’ll say, yes, omega-3s are beneficial for your heart.”

GOED recommends maintenance doses of 500mg/day of omega-3s containing EPA and DHA. The American Heart Association recommends 1,000mg/day for the secondary prevention. For certain cardio conditions, 2-4g/day might be necessary.

“It’s amazing,” Ismail said. “We know we don’t get enough in our diet, you supplement and blood levels go up. How can you say you shouldn’t take omega-3s?”

He did say that eating fish is every bit as good as even high-dose fish oil supplements. “Salmon is a more potent and powerful way to deliver omega-3s than supplements,” he said. “But not everyone wants to eat salmon that often.”

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.